Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
This study is currently recruiting participants.
Verified April 2013 by Teva Pharmaceutical Industries
Study NCT01624480   Information provided by Teva Pharmaceutical Industries

First Received on June 18, 2012.   Last Updated on April 29, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Narcolepsy
More general conditions related to this trial
Disorders of Excessive Somnolence
Dyssomnias
Mental Disorders
Nervous System Diseases
Sleep Disorders
Sleep Disorders, Intrinsic
Interventions listed in this trial
Armodafinil
Additional drug interventions recognized in this trial
Modafinil
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Stimulants
Neuroprotective Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Teva Pharmaceutical Industries


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services